__timestamp | Alpine Immune Sciences, Inc. | Summit Therapeutics Inc. |
---|---|---|
Wednesday, January 1, 2014 | 12199547 | 15635076 |
Thursday, January 1, 2015 | 16054000 | 23943601 |
Friday, January 1, 2016 | 23316000 | 23689111 |
Sunday, January 1, 2017 | 10626000 | 41006114 |
Monday, January 1, 2018 | 28970000 | 51379106 |
Tuesday, January 1, 2019 | 35847000 | 32705593 |
Wednesday, January 1, 2020 | 27185000 | 53274000 |
Friday, January 1, 2021 | 58742000 | 85352000 |
Saturday, January 1, 2022 | 70243000 | 51999000 |
Sunday, January 1, 2023 | 80904000 | 59471000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Summit Therapeutics Inc. and Alpine Immune Sciences, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D). From 2014 to 2023, Summit Therapeutics consistently outpaced Alpine Immune Sciences in R&D spending, peaking in 2021 with a 45% higher investment. However, Alpine Immune Sciences has shown remarkable growth, increasing its R&D expenses by over 560% from 2014 to 2023. This trend highlights a strategic shift towards innovation, positioning both companies as key players in the biotech industry. As they continue to push the boundaries of medical science, their commitment to R&D underscores the importance of innovation in driving future breakthroughs.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.